Xingyu Chen | Cancer Biology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Xingyu Chen | Cancer Biology | Young Scientist Award

Research Bioinformatician | Cedars-Sinai Medical Center | United States

Dr. Xingyu Chen is a research bioinformatician and computational oncologist specializing in sex chromosome genomics, cancer immunology, and precision medicine. His work has revealed the Loss of the Y Chromosome (LOY) as a causal driver of cancer immune evasion in men, demonstrating its role in tumor progression, immune dysfunction, and therapy resistance. He pioneered the development of the world’s first Sex Chromosome-Aware Genomic Large Language Model, integrating AI with genomic data to enhance cancer diagnostics and guide precision therapies. His research combines multi-omics analysis, single-cell and spatial transcriptomics, and deep-learning models to uncover mechanisms of tumor evolution, T-cell exhaustion, and sex-specific cancer vulnerabilities. Chen has contributed to high-impact publications in journals such as Nature, Oncogene, and International Journal of Molecular Sciences, with 800 citations, an h-index of 15, and multiple first/co-first author contributions, reflecting his influence in the field. His work extends to translational applications, including LOY-informed cellular therapies and radiogenomic predictive algorithms for bladder cancer, leading to patentable innovations. He has also mentored trainees, co-supervised projects, and collaborated with international institutions to advance integrative cancer genomics and AI-driven therapeutics. Overall, his research advances the understanding of male-biased cancer mechanisms and supports the development of innovative diagnostic and therapeutic strategies, bridging fundamental biology, computational modeling, and clinical applications to improve outcomes for men with cancer.

Featured Publications

Abdel-Hafiz, H. A., Schafer, J. M., Chen, X., Xiao, T., Gauntner, T. D., Li, Z., … et al. (2023). Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature, 619(7970), 624–631.

Jin, Y., Wang, Z., He, D., Zhu, Y., Chen, X., & Cao, K. (2021). Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma. Cancer Medicine, 10(23), 8693–8707.

Ayesha Ahmed | Cancer Biology | Research Excellence Award

Published on by Young Scientists Awards

Ms. Ayesha Ahmed | Cancer Biology | Research Excellence Award

Roosevelt University | United States

Ms. Ayesha Ahmed is an emerging pharmacist and pharmaceutical sciences researcher with a strong interdisciplinary foundation spanning clinical practice, pharmaceutical manufacturing, research coordination, and academic support. Her academic and professional journey reflects a commitment to advancing global healthcare through evidence-based practice, scientific inquiry, and collaborative learning. She has contributed to research projects that integrate stakeholder engagement, strategic planning, and analytical evaluation, enabling the development of targeted research approaches within the pharmaceutical and healthcare sectors. Her scientific interests encompass drug formulation, regulatory science, clinical pharmacy, and translational research aimed at improving therapeutic outcomes. She has co-authored publications exploring corrosion-resistant polymer modifications for industrial applications, barriers and enablers influencing community pharmacists’ participation in deprescribing initiatives, and molecular insights into CRP interactomes related to cellular signaling and tumorigenicity. These works demonstrate her ability to engage with both laboratory-based and clinical-conceptual research, bridging basic science with healthcare practice. She possesses strong communication and instructional skills refined through academic tutoring roles, where she supported learners in developing scientific writing, analytical reasoning, and pharmacy-related competencies. Her international training exposure has strengthened her understanding of pharmaceutical manufacturing processes, regulatory frameworks, and quality-assurance practices within diverse healthcare systems. Motivated by a passion for patient-centered care, interdisciplinary research, and global health development, she continues to expand her expertise through advanced study in pharmaceutical sciences. She aims to contribute to innovations in drug development, clinical decision-making, and pharmacy practice through research that supports safety, effectiveness, and equitable access to healthcare.

Featured Publication

Gerhardt, A., Nanakaliy, D., Shah, H. D., Sarfaraz, S., Madigan, C., Downing, M., Elliott, R. P., Dipto, R., Vrapciu, B., Noetzel, J. W., et al. (2025). Evaluating the CRP interactome: Insights into possible novel roles in cellular signaling and tumorigenicity. Current Issues in Molecular Biology, 47(12), Article 1003.

Elshazly, M., Wilkinson, J., Jawad, S., Ahmed, A., ElGeed, H., & Yusuff, K. B. (2025). Enablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar. PLOS ONE, 20(1), Article e0316363.

Ali Yousefi | medicinal chemistry | Best Researcher Award

Published on by Young Scientists Awards

Mr. Ali Yousefi | Medicinal Chemistry | Best Researcher Award

Ali Yousefi, an Iranian medicinal chemist born in 1998, is a Ph.D. scholar at Tabriz University of Medical Sciences and an emerging researcher at the University of Kashan’s Essential Oils Research Institute. With a strong foundation in pure and medicinal chemistry, his research explores the synthesis and biological evaluation of bioactive compounds, integrating AI and natural product chemistry. He has contributed to cutting-edge publications, presented at national conferences, and taken part in interdisciplinary collaborations. Ali is deeply invested in drug discovery, natural product isolation, and cancer-related research, aiming to bridge traditional remedies with modern medicinal approaches.

Profile

Scopus

🎓 Education 

Ali Yousefi earned a B.Sc. in Pure Chemistry (2017–2023) and an M.Sc. in Medicinal Chemistry (2021–2023) from the University of Kashan, Iran, through its Distinguished Talent Program. Currently, he is pursuing a Ph.D. in Medicinal Chemistry (2023–2027) at the Faculty of Pharmacy, Tabriz University of Medical Sciences. His educational focus spans organic synthesis, drug design, and biological screening of novel compounds. His academic trajectory reflects both rigorous training and an innovative outlook, particularly in linking medicinal chemistry with computational modeling and natural compound exploration for therapeutic applications.

💼 Experience 

Ali has served as a teaching assistant and lecturer in undergraduate and graduate courses, including Organic Chemistry, Medicinal Chemistry, and Analytical Chemistry. He is actively involved in industrial R&D at the Shahid Ardeshir Hosseinpour Incubation Center, contributing to the synthesis and localization of Sugammadex production. A key member of the Essential Oils Research Institute since 2007, he has also contributed to AI-healthcare integrations such as Pharm Chatbot AI. At Tabriz University, he supports research in marine-derived anticancer agents, merging pharmaceutical innovation with machine learning in biological predictions.

🏅 Awards and Honors 

Ali was selected for the Distinguished Talent Program at the University of Kashan for his M.Sc. studies in Medicinal Chemistry. He has earned national recognition through his publications in high-impact journals and presentations at prestigious chemistry and medical symposia. His work in AI-integrated drug development and radiation side-effect prediction has positioned him as a promising young scientist. His role in cross-institutional industrial collaborations also demonstrates his leadership in translational research and his early career distinction in medicinal chemistry and bioinformatics.

🔬 Research Focus 

Ali’s research centers on drug discovery through the design, synthesis, and evaluation of biologically active compounds such as resveratrol and bromophenol derivatives. He is deeply interested in antioxidant, anticancer, and antimicrobial agents from natural and marine sources. His work spans computational drug design, structure-activity relationship studies, and AI applications in predicting biological responses. He also explores electrochemical biosensing and nanomaterial interfaces for biomedical diagnostics. Overall, Ali’s interdisciplinary approach bridges chemistry, pharmacology, and data science for impactful advancements in precision medicine.

📝 Conclusion

Ali Yousefi is an excellent candidate for the Best Researcher Award, demonstrating a compelling blend of academic brilliance, innovative thinking, practical application, and multidisciplinary research expertise. His active contributions in medicinal chemistry, machine learning for healthcare, natural products, and industrial pharma solutions highlight both depth and breadth of scientific engagement. With enhanced international collaboration and greater focus on innovation outputs (patents, grants), he is poised to become a rising star in pharmaceutical and biomedical research. Given his early career accomplishments and forward-thinking approach, he is strongly recommended for recognition through this prestigious award.

Publication

  • Title: Design, Synthesis and Antioxidant, Anticancer and Antimicrobial Activity Evaluation of Novel Resveratrol Derivatives

  • Year: 2025

  • Authors: Ali A. Yousefi, Abdolrasoul H. Ebrahimabadi, Hourieh Sadat Oboudatian